Our reference: YPRRV 1438
P-authorquery-v14
AUTHOR QUERY FORM
Journal: YPRRV
Please e-mail your responses and any corrections to:
E-mail: corrections.esch@elsevier.sps.co.in
Article Number: 1438
Dear Author,
Please check your proof carefully and mark all corrections at the appropriate place in the proof. It is crucial that you NOT make direct edits to
the PDF using the editing tools as doing so could lead us to overlook your desired changes. Rather, please request corrections by using the
tools in the Comment pane to annotate the PDF and call out the changes you would like to see. To ensure fast publication of your paper please
return your corrections within 48 hours.
For correction or revision of any artwork, please consult http://www.elsevier.com/artworkinstructions.
Any queries or remarks that have arisen during the processing of your manuscript are listed below and highlighted by flags in the proof.
Location in
article
Query / Remark: Click on the Q link to find the querys location in text
Please insert your reply or correction at the corresponding line in the proof
Q1
Your article is registered as a regular item and is being processed for inclusion in a regular issue of the journal.
If this is NOT correct and your article belongs to a Special Issue/Collection please contact l.vasu@elsevier.com
immediately prior to returning your corrections.
Q2
The author names have been tagged as given names and surnames (surnames are highlighted in teal color).
Please confirm if they have been identified correctly.
Please check this box or indicate
your approval if you have no
corrections to make to the PDF file
Thank you for your assistance.
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
Paediatric Respiratory Reviews xxx (xxxx) xxx
1
Contents lists available at ScienceDirect
Paediatric Respiratory Reviews
Review
5
4 Q1
6
Weaning oxygen in infants with bronchopulmonary dysplasia
8 Q2
9
10
11
12
13
14
15
Lucy H. Everitt a,f, Adejumoke Awoseyila b,f, Jayesh M. Bhatt c,f, Mark J. Johnson d,e,f, Brigitte Vollmer e,g,f,
Hazel J. Evans a,f,⇑
a
Pr
o
7
of
2
Department of Respiratory Paediatrics, Southampton Children’s Hospital, Southampton, UK
Department of Paediatrics, Basingstoke and North Hampshire Hospital, Basingstoke, UK
c
Department of Respiratory Paediatrics, Nottingham Children’s Hospital, Nottingham, UK
d
Department of Neonatal Medicine, Southampton Children’s Hospital, Southampton, UK
e
NIHR Biomedical Research Centre Southampton, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, UK
f
Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
g
Neonatal and Paediatric Neurology, Southampton Children’s Hospital, Southampton, UK
b
16
17
Educational Aims
18
The reader will come to:
20
Understand that sustained and intermittent hypoxia (IH) has adverse consequences for respiratory, growth and neurodevelopmental outcomes in preterm infants.
Be aware that the implementation and weaning of oxygen therapy in preterm and term infants should refer to age appropriate
oximetry reference ranges.
Be aware that data output from pulse oximeters and oxygen desaturation indices are influenced by technological features of
recording devices.
Recognise that modern oximeters have shorter averaging times and have the ability to exclude motion artefact.
Understand that a structured approach to home oxygen weaning is associated with improved outcomes in preterm infants with
BPD following discharge from the neonatal unit.
24
25
26
27
28
29
3 1
1
4
32
33
a r t i c l e
i n f o
Keywords:
Bronchopulmonary dysplasia
Oxygen
Oximetry
Preterm infant
Saturations
Sleep study
U
nc
34
35
36
37
38
39
40
ct
23
re
22
a b s t r a c t
or
21
ed
19
Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease commonly seen in preterm infants
as the sequelae following respiratory distress syndrome. The management of evolving BPD aims to minimise lung injury and prevent the impact of hypoxia and hyperoxia. Proposed morbidities include respiratory instability, pulmonary hypertension, suboptimal growth, altered cerebral oxygenation and longterm neurodevelopmental impairment. The ongoing management and associated morbidity present a
significant burden for carers and healthcare systems. Long-term oxygen therapy may be required for variable duration, though there is a lack of consensus and wide variation in practise when weaning supplemental oxygen. Furthermore, a shift in care towards earlier discharge and community care underlines the
importance of a structured discharge and weaning process that eliminates the potential risks associated
with hypoxia and hyperoxia. This review article describes recent evidence outlining oxygen saturation
reference ranges in young infants, on which structured guidance can be based.
Crown Copyright Ó 2020 Published by Elsevier Ltd. All rights reserved.
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
⇑ Corresponding author at: Southampton Children’s Hospital, Tremona Road,
Southampton SO16 6YD, UK.
E-mail address: hazel.evans@uhs.nhs.uk (H.J. Evans).
INTRODUCTION
57
Despite advances in neonatal care over the last decade with various prevention strategies, the incidence of chronic lung disease
(CLD) remains high. For extremely preterm infants (birth before
28 weeks of gestation) at risk of respiratory distress syndrome
58
https://doi.org/10.1016/j.prrv.2020.10.005
1526-0542/Crown Copyright Ó 2020 Published by Elsevier Ltd. All rights reserved.
Please cite this article as: L.H. Everitt, A. Awoseyila, J.M. Bhatt et al., Weaning oxygen in infants with bronchopulmonary dysplasia, Paediatric Respiratory
Reviews, https://doi.org/10.1016/j.prrv.2020.10.005
59
60
61
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
101
Bronchopulmonary dysplasia and pulmonary hypertension
102
112
Pulmonary hypertension develops in 20–40% of infants with
BPD and contributes to morbidity and mortality [15,16,19]. The
risks are greatest in very preterm (born <32 weeks of gestation)
and extremely low birth weight infants (<1000 g), as well as
infants with additional cardiovascular anomalies [20,21]. Retrospective studies of infants with BPD and associated PHT suggest
mortality rates range from 14% to 38% [22]. Chronic hypoxaemia
is a well-established cause of PHT and lack of a structured oxygen
weaning programme is associated with increased prevalence of
PHT in infants with BPD [9]. With appropriate oxygen supplementation this is reversible in the majority of cases [23].
113
Hypoxia and growth
114
Despite aggressive nutritional support with both enteral and
parenteral nutrition in more recent years, a large proportion of
infants born <28 weeks gestation demonstrate growth failure at
36 weeks post conceptual age (PCA).
Evidence suggests that mean saturations <92%, are associated
with suboptimal growth [18] and necrotising enterocolitis [24] in
infants with CLD. However targeting higher saturations (95–98%
versus 96–99%) from 32 weeks PCA onwards in extremely preterm
U
nc
103
or
100
PROPOSED MORBIDITY RELATING TO SUSTAINED AND
INTERMITTENT HYPOXIA
99
104
105
106
107
108
109
110
111
115
116
117
118
119
120
121
Neurodevelopmental outcome
159
The importance of avoiding prolonged hypoxaemia in early
neonatal life cannot be over emphasised. Pooled meta-analysis
data of the Surfactant Positive Airway Pressure and Pulse Oximetry
Trial (SUPPORT), Canadian Oxygen Trial (COT), and BOOST studies
observed no significant difference between different oxygen saturation targets (85–89% versus 91–95%) on the primary composite
outcome of death or major disability at a corrected age of 18–
24 months. However, lower saturations were associated with a
higher risk of death, albeit with a lower risk of interventions for
retinopathy of prematurity (ROP) [24].
The relationship between BPD and neurodevelopment is complex. There is evidence that in extremely preterm infants BPD is
associated with adverse neurodevelopmental outcome including
cognition, motor performance, speech and language, behaviour,
and often poor academic attainment [7,8,31].
Data on the impact of short hypoxic events is emerging. Horne
et al utilised daytime polysomnography and near infrared spectroscopy to demonstrate that short hypoxic events (defined as
apnoea >3 second duration) in ex-preterm infants are associated
with decreases in heart rate and cerebral oxygenation, which were
more marked at 2–3 months and 5–6 months than at 2–4 weeks
post term corrected age [32]. These greater oxygen deficits coincide with rapid brain growth and metabolic brain activity as well
as physiological anaemia. Whilst supplemental oxygen postdischarge from the neonatal unit does not appear to impact on
neurodevelopmental outcomes measured using the Bayley Scales
160
of
66
122
Pr
o
65
infants conferred no significant benefit on growth in either the
Benefit Of Oxygen (BOOST) initial trial [25] or Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
(STOP-ROP) multicentre trial [26].
However, once discharged infants with BPD receiving supplementary home oxygen have demonstrated small improvements
in growth compared to those managed in room air [27]. Considering that growth failure is common in infants with BPD, any small
improvements in growth may potentially support lung recovery.
Infants with lower mean saturations are predisposed to episodes of IH [12] and this is exacerbated in infants with BPD (see
Table 2) [28,29]. Certainly, infants with severe lung disease are
more predisposed to hypoxic events with exertional activities.
Wang et al examined the impact of BPD severity on oxygen saturations during feeding at 2, 4 and 6 months CGA, and growth of very
low birth weight (VLBW, <1500 g) preterm and term infants during
infancy. Studies were undertaken in room air. During rest immediately prior to feeding mean saturation in all groups were >97%.
VLBW infants with severe BPD exhibited significantly lower mean
saturations during feeding and more significant desaturations
<90% presumably due to increased respiratory demands. These
infants displayed slower growth compared to term and VLBW
infants with mild BPD at all time points [17]. Animal models have
demonstrated that even in the absence of respiratory disease IH
events are associated with impaired growth in the first few weeks
of postnatal life [30]. It is thus possible that both IH events and
increased respiratory demands contribute to impaired growth in
infants with BPD.
Whilst the impact of hypoxia on growth may reflect a complex
mix of increased metabolic demand alongside increased vulnerability to respiratory infection, this data supports the need to ensure
adequate oxygenation during periods of activity. Optimising the
growth of these infants with increased metabolic requirements,
and eliminating the potential adverse effect of hypoxaemia in the
first few months of life may aid successful oxygen weaning. Regular monitoring to ensure adequate growth and nutrition is advised
[17].
ed
64
(RDS), the incidence of bronchopulmonary dysplasia (BPD), defined
as requiring supplemental oxygen for at least 28 days or continued
respiratory support at 36 weeks post conceptual age (PCA), ranges
from 48 to 68% between centres [1,2]. Almost one third of babies
<32 weeks’ gestation that were admitted to a UK neonatal unit in
the period 2016–2018, developed BPD (6931 infants) [3]. BPD
accounts for 68% of children in the UK who receive home oxygen
[4].
This resultant morbidity causes a huge burden on both carers
and healthcare systems, with 49% of infants with BPD requiring
rehospitalisation in the first year of life. Poor respiratory health
and impaired lung function have been shown to persist beyond
infancy into childhood and adolescence [5,6]. Although the relationship between BPD and neurodevelopment is complex, there
is evidence that in extremely preterm infants BPD is associated
with adverse neurodevelopmental outcome [7,8].
More recently, care has shifted from inpatient provision of respiratory support and an associated prolonged hospital stay, to earlier discharge and integration with parents/carers in the
community. The ready availability of oxygen provision in the home
has facilitated this practise and supported wider opportunity for
infant social stimulation as well as reducing financial demand.
The role of healthcare providers is to ensure a smooth discharge
process whilst reducing the potential risks associated with hypoxia
or hyperoxia at a time when these infants are no longer on continuous cardiorespiratory monitoring. The potential for subsequent
complications if these infants are ineffectively managed is high [9].
Whilst the impact of sustained lower baseline oxygen saturations is increasingly clear [10–12], the effect of brief hypoxic
events to which infants are particularly susceptible is only beginning to become evident. These are caused by short central apnoeas
as a result of respiratory instability in early infancy which reduce
over the first few months of life as respiratory patterns mature
and stabilise [13,14]. The consequences of oxygen deprivation
may include pulmonary hypertension (PHT) [15,16], altered
somatic growth [17,18] adverse effects on neurodevelopment
[7,10] and an increased risk of acute life-threatening events.
ct
63
re
62
Paediatric Respiratory Reviews xxx (xxxx) xxx
2
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
Paediatric Respiratory Reviews xxx (xxxx) xxx
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
188
189
of Infant Development [33], these brief hypoxic events may lead
over time to adverse behavioural and neurocognitive functioning
similar to that associated with sleep disordered breathing (SDB)
[32].
Healthcare utilisation
191
Associations between supplemental oxygen use, respiratory
and healthcare utilisation are conflicting. Greenough et al. reported
a significantly lower total cost of care over a two-year period for
infants discharged from centres with high rates of home oxygen
therapy (HOT) [34]. Longer desaturation events in extremely preterm infants at TEA are associated with greater healthcare utilisation over the first two years of life [29].
Conversely DeMauro et al reported a higher rate, and greater
duration of hospitalisation, in extremely preterm infants with
BPD over a 2-year period receiving supplemental oxygen following
propensity score matching at 36 weeks PCA. Infants receiving oxygen were also more likely to have increased medical resource use
(respiratory medication and equipment) and undergo tracheostomy insertion during the first two years of life, suggestive
of respiratory morbidity. The STOP-ROP RCT observed as a secondary outcome that pneumonia and pulmonary exacerbations
occurred more frequently in infants assigned to higher saturations
(96–99% versus 89–94%) from 35 weeks PCA [26]. Importantly, a
third of infants in the supplemental arm discontinued oxygen at
a mean PCA of 37 weeks as they had reached the study endpoint
and thus may not be applicable to babies discharged in oxygen.
The perceived vulnerability of an infant requiring supplemental
oxygen may influence parental health seeking behaviours and
healthcare attendance. Children receiving home oxygen are more
likely to have home pulse oximeters [27] which may affect thresholds for presentation with respiratory symptoms. HOT commonly
facilitates a more direct and ‘open access’ pathway to secondary
healthcare services and clinicians may consider these infants vulnerable contributing to cautious management and hospital readmission. The impact of oxygen supplementation on growth and
respiratory outcomes at 6 months on infants discharged from the
Neonatal Intensive Care Unit (NICU) is currently the focus of an
RCT [35].
Prescribing supplemental home oxygen clearly requires a careful balance between the potential risks and benefits for infants
with BPD. The uncertainties around the benefits or otherwise of
supplemental oxygen support the need for supervised weaning
for infants discharged from NICU in oxygen.
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
U
nc
228
SETTING CRITERIA FOR OXYGEN REQUIRMENT AT DISCHARGE
279
Since publication of the ATS guidance [37] in 2018 the evidence
base has expanded in relation to reference ranges for oxygen saturation parameters in healthy preterm and term infants
[13,28,29,46–48]. Using this data, we propose a structured weaning programme for infants with BPD at term equivalent age
(TEA), receiving supplemental oxygen post- discharge from NICU.
This guidance aims to define target oxygen saturations relative to
otherwise healthy infants and importantly demonstrates the influence of rapid maturation both in tidal volumes and saturation
indices in the first few weeks of life beyond term and how these
can impact on oxygen weaning.
280
ct
194
re
193
or
192
246
ed
190
is a limited understanding of technological considerations that
affect data output from oximeters [41].
In the absence of a structured weaning plan, the median age at
which infants are weaned off oxygen ranges from 10 to 15 months
[9,42] and is unsupervised in as many as one third of infants [9].
Importantly, structured weaning targeting oxygen saturation
levels within recommended ranges has been demonstrated to
reduce the duration of oxygen supplementation with the rate of
weaning being more rapid in those infants having more regular
episodes of continuous saturation monitoring [42]. Active weaning
and a shorter home oxygen duration treatment is associated with
enhanced parental quality of life [43].
Batey et al demonstrated a 10-month reduction in duration of
home oxygen following introduction of a structured weaning programme without adverse effects. Close initial monitoring of infants
pre-discharge did lead to an increase in the number of infants
receiving supplemental oxygen at discharge, however, there was
an overall reduction in HOT. No significant difference was observed
between hospital readmission rates following the intervention
[42]. Supervised weaning is associated with a lower incidence of
PHT [44].
Since publication of the American Thoracic Society (ATS) guidance providing a ‘strong recommendation based on very lowquality evidence’ for the prescription of home oxygen in patients
with BPD complicated by chronic hypoxaemia [37], there has been
a progressive increase in evidence providing reference oxygen saturation data for preterm infants. More recently, the European Respiratory Society (ERS) recognised the urgent need for evidence to
support guidance in the long term management of BPD [36] and
the Thoracic Society of Australia and New Zealand delivered a position statement to address the considerable variation and limited
objective evidence for the use of long term supplemental oxygen
in CLD [45].
of
187
Pr
o
186
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
281
282
283
284
285
286
287
288
289
290
229
A STRUCTURED APPROACH TO WEANING
230
Current practise
Baseline mean saturations
291
231
National guidelines for initiating, monitoring and weaning
infants from supplemental oxygen following discharge from NICU
lack an evidence base [36,37], which has changed little over the
past decade. Historic guidance has been subject to weak evidence
and influenced by observational data.
This lack of an evidence base has led to wide variation in international practise with both a lack of consensus for initiating oxygen therapy particularly around mean saturation thresholds for
prescribing oxygen and optimum target saturations [38,39]. Variation in target saturations impacts on weaning preterm infants from
supplemental oxygen therapy [40]. Rhein et al. surveyed weaning
practise in the USA and reported that only 8% of pulmonologists
followed a standardised weaning protocol. Growth was felt to be
an important consideration when weaning infants but other variables such as hospitalizations lacked consensus [41]. Notably, there
British Thoracic Society (BTS) (2009) guidelines are most commonly used to wean oxygen in 45% of UK centres [49]. This guidance suggests maintaining oxygen saturations at 93% and
allowing <5% of the study time with saturations <90% during a
stable recording period [50].
However, this predates the widespread use of new generation
oximeters which can reliably detect brief drops in oxygen saturations due to shorter averaging times and also effectively remove
artefact due to motion. Such features are vital in infants who regularly exhibit brief hypoxic events secondary to central apnoeas
[51], and restless young children [41]. These oximeters are now
widely available and are important advances in the investigation
of children for SDB [14,51]. Shorter averaging times (usually maximum 3 seconds) avoid smoothing out of brief desaturation events
(Fig. 1) [41].
292
232
233
234
235
236
237
238
239
240
241
242
243
244
245
3
293
294
295
296
297
298
299
300
301
302
303
304
305
306
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
Paediatric Respiratory Reviews xxx (xxxx) xxx
328
Desaturation indices
333
Oxygen desaturations indices (ODI) are defined as the average
number of desaturation episodes per hour and are typically
reported as ODI3 and ODI4, referring to the number of times per
hour where the oxygen saturation falls by at least 3% and 4% from
baseline respectively. At less deviance from baseline, ODI3 incorporates ODI4 and is therefore equivalent or greater in value (Tables
1 And 2). ODI are increasingly reported by clinicians largely due to
the increasing relevance they play in the diagnosis of SDB [41]. In
2012, the American Academy of Sleep Medicine (AASM) revised the
scoring criteria for SDB referring to ODI3 rather than ODI4; a shift
has been recently replicated in the Australasian Sleep Association
(ASA) pulse oximetry guidelines.
Importantly, reference ranges for desaturation indices in older
children are not applicable to young infants who regularly exhibit
brief hypoxia events secondary to central apnoeas [14,51].
Recently, normative oximetry data has been reported for preterm
infants at TEA [28,29,46] and healthy term infants at birth [46],
2 weeks [13], 1 [48], and 3 months [13,48] post term (Table 1).
Mean Oxygen Saturations, Oxygen Desaturation Index >3%
(ODI3) and >4% (ODI4) from baseline/hour, Minimum Saturations
(Sat Min), percentage time with saturations below 90% (% time
<90%).
These data clearly demonstrate maturation in ODI over the first
4 months of life post term [14], presumably due to maturational
stability of breathing patterns. Williams et al demonstrated that
healthy preterm infants at term have similar 3% ODI to term
infants [46], thus suggesting that prematurity alone does not
markedly impact on central apnoea and ODI3.
A feature of 3% and 4% ODI is the marked heterogeneity
between infants. This may reflect relatively small infant numbers
in the published literature [46,48]. Certainly, larger studies would
be beneficial to determine whether reference ranges can be defined
more tightly.
Extremely preterm infants with BPD appear to be particularly
susceptible to brief hypoxic events and higher ODI3 are observed
at TEA (Table 2) [28,29,47]. These data most likely reflect greater
334
Pr
o
of
positional statement [11,45], as well as normative oximetry data
for healthy preterm infants (see Table 2) [28,29,46]. Considering
these reference data, it is possible that the proposed baseline target
saturations outlined are conservative and should conceivably be
higher at 95%.
Fig. 1. Influence of the averaging time on the number of desaturations for an alarm
threshold at 80% SpO2. An averaging time of 3 s (green) results in six desaturations,
while an averaging time of 10 s (red) or 16 s (blue) results in three and one
desaturation(s), respectively. Reproduced from Vagedes et al. [52].
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
U
nc
327
ed
310
ct
309
re
308
Additionally, this smoothing may artificially lower mean saturations resulting in the delivery of a higher oxygen concentration
to maintain target range [53], and more infants perceived to reach
agreed thresholds for supplemental oxygen. Technological aspects
of oximeters that affect data output must be considered to avoid
misinterpretation [41].
Studies using new generation oximeters demonstrate that both
healthy term-born [13,48] and healthy preterm infants at TEA
[28,29,46] have mean oxygen saturations >95%. Similarly, extremely preterm infants with significant lung disease also have mean
saturations >95% [28,29], although it should be noted that in these
cases mean saturation data is likely to have been influenced by the
respiratory support (CPAP and oxygen) delivered to some infants at
the time of oximetry studies (Tables 1 And 2).
Once an infant with BPD reaches term and achieves mature retinal vascularisation (as documented by ophthalmologic examination), a target saturation value of greater than 93% is
recommended. This provides a ‘‘buffer” zone against dips in oxygen
saturations and hypoxaemia that lower targets <92% do not. Proposed recommendations are in accordance with BTS guidance
[50], and the recent Australian and New Zealand Thoracic Society
or
307
Table 1
Normative oximetry data for healthy term infants. Mean Oxygen Saturations, Oxygen Desaturation Index >3% (ODI3) and >4% (ODI4) from baseline/hour, Minimum Saturations
(Sat Min), percentage time with saturations below 90% (% time <90%).
Author
Gestation (weeks)
(number)
Timing of oximetry
(post conceptual age, weeks)
Mean saturations (%)
Williams LJ (2019)
Preterm at day 2/3
Williams LJ (2019)
Preterm at term
equivalent
35 (34–36)
(N = 43)
35 (34–36)
(N = 43)
35 (34–36)
97.8
(97.1–98.3)
98.8
(98.4–99.4)
32.8
(25.9–41.4)
Williams LJ (2019)
Term at day 2/3
40 (39–42)
(N = 42)
40 (39–42)
97.9
(96.7–98.9)
29.3
(23.5–36.6)
Terrill PI (2015) Term
at 2 weeks
40 (38–42)
N = 30
(40–44)
97.8
(95–99)
27.2
(21.2–33.1)
Evans HJ (2018) Term
at 1 month
39 (37–42)
(N = 45)
44 (43–44)
97.1
(13.7–18.6)
Terrill PI (2015) Term
at 3 months
40 (38–42)
N = 25
(51–56)
98.9
(97–100)
Evans HJ (2018) Term
at 3 months
39 (37–42)
(N = 38)
56 (54–57)
97.7
(97.2–98.1)
40
4
Sat Min (%)
80.4
(78.8–82.0)
ODI3
25.4
(22.0–28.8)
ODI4
% time <90%
1.3 (<92%)
0.0–6.3
16.2
(13.7–18.6)
0.39
(0.26–0.55)
8.12
(6.46–9.77)
0.11
(0.06–0.20)
10.0
(7.4–12.6)
84.7
(83.3–86.1)
13.9
(11.4 –16.5)
329
330
331
332
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
Paediatric Respiratory Reviews xxx (xxxx) xxx
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
Table 2
Normative oximetry data for extreme preterm infants and healthy late preterm infants. Mean Oxygen Saturations (SAT50), Oxygen Desaturation Index >3% (ODI3) and >4% (ODI4)
from baseline/hour, Minimum Saturations (Sat Min), percentage time with saturations below 90% (% time <90%).
Gestation (weeks)
(number)
Timing of oximetry
(post conceptual age, weeks)
Mean saturations (%)
Sat Min (%)
ODI3
ODI4
% time < 90%
Wellington G (2018)
Preterm at term
equivalent
32 (24–36)
(N = 38)
37 (35–42)
97.8
(97.1–98.7)
60
(45.5–66)
80
(55–105)
53
(34–76)
1.95
(0.8–4.68)
Terrill PI (2018)
Preterm at term
equivalent
24 (23–25)
N = 37
40 (37–42)
96.1
(95.4–96.8)
54.8
(47.2–62.5)
43.8
(37.0–50.6)
7.56
(5.1–10.0)
376
Weaning infants from oxygen
377
The amount of oxygen inspired by an infant on supplemental
oxygen depends on the amount of extraneous room air that is
372
373
374
U
nc
or
re
ct
ed
378
inspired. In infants weighing <1.5 kg, the amount of extraneous
room air that dilutes supplemental oxygen with inspiration is minimal. However, this dilutional effect increases with growth. Finer
et al demonstrated that at an oxygen flow of 0.2 l/min, an infant
weighing <1.5 kg can achieve a fraction of inspired oxygen (FiO2)
of up to 95% when measured at the back of the oropharynx
whereas infants >1.5 kg will achieve a maximum FiO2 of approximately 70% (mean 47%) [48]. Accordingly, very small changes in
inspired oxygen can have large effects on saturations in infants
<1.5 kg, but >2.5 kg changes of 0.1 l/min oxygen result in only
small changes in oxygen saturations [54]. On this basis, oxygen
Pr
o
375
vulnerability to hypoxaemia from central apnoeas. This may be as
a result of lung damage contributing to PHT and impaired
diffusion.
These data confirm the need for an approach to initiation and
weaning of oxygen which takes in to account age specific reference
ranges alongside the severity of lung disease.
370
371
of
Author
Fig. 2. Structured weaning programme for infants with BPD requiring oxygen on discharge into the community. Adapted from Khetan et al: Advances in Neonatal Care 2016
[61].
5
379
380
381
382
383
384
385
386
387
388
389
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
Paediatric Respiratory Reviews xxx (xxxx) xxx
391
can be weaned safely in increments of 0.1 l/min in infants over
2.5 kg and 0.2 l/min in infants >10 kg [42].
392
Using pulse oximetry to monitor and wean supplemental oxygen
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
U
nc
433
434
435
436
437
438
439
440
441
442
443
CONCLUSION
462
BPD is responsible for over two thirds of children receiving UK
home oxygen, and is associated with significant morbidity and
high health care utilisation. Currently, there is much heterogeneity
in the implementation, monitoring and weaning of LTOT which
reflects a limited evidence base, and the need for higher quality
prospective studies. Maintaining healthy oxygen saturations and
avoiding the consequences of oxygen deprivation is likely to
improve outcomes. Whilst a standardised weaning programme
may result in an initial increase in infants receiving oxygen at discharge, the benefits include reduced hospital readmissions, more
rapid weaning and the potential effects of unwanted hypoxia such
as pulmonary hypertension. Increasingly modern oximeters with
short averaging times able to exclude motion artefact are widely
available, and offer many advantages particularly in relation to
the availability of age specific reference ranges for this cohort of
infants.
463
PROPOSED WORKFLOW
479
We suggest that initiating and weaning oxygen therapy is done
as a staged and gradual process using age appropriate reference
ranges for the oximeter that is being used. Targeting mean oxygen
saturations greater than 93%, in order to avoid adverse outcomes
that may result from hypoxaemia is proposed. Short desaturations
occur in healthy term and preterm infants and it is acceptable to
wean oxygen in the presence of these within a specified range.
The recommendations set out in this article are particularly aimed
at infants born prematurely with BPD but could be applied to other
infants with CLD and those with SDB such as periodic breathing.
However, infants with complex issues such as cyanotic congenital
heart disease may not necessarily fit into the suggested pathway
and advice should be sought from specialist teams.
480
DIRECTIONS FOR FUTURE RESEARCH
493
of
397
Pr
o
396
444
ed
395
There is much uncertainty regarding the optimal approach to
weaning supplemental home oxygen and a lack of consensus
regarding best practise [37,50]. Rhein et al. examined the impact
of a home oxygen management strategy and the analysis of
recorded home oximetry data alongside standard monthly clinic
visits on the duration of home oxygen [43]. Recorded home oximetry data was associated with a shorter duration of HOT in preterm
infants that required oxygen at discharge. Within this study, the
decision regarding oxygen weaning was based on a structured
algorithm involving 20 min daytime oximetry challenges to determine whether infants could maintain saturations >93%. Importantly, the level of infant activity at the time of clinic assessment
and oxygen weaning was not reported [43].
The duration of infant monitoring during the daytime requires
consideration and particularly whether this should contain periods
of feeding or activity, that is times most likely to stress respiratory
reserve. A reduction in saturations during infant feeding is
reported [17], and on this basis it may be appropriate to initially
attempt gradual weaning during periods of exertion such as feeding [55]. However, such short term, awake recording of saturations
may not accurately predict those during prolonged sleep [18] when
episodes of rapid eye movement (REM) sleep predispose to central
apnoeas and desaturations [56]. A period of overnight monitoring
is therefore crucial in addition to daytime observations and if
undertaking regularly has been demonstrated to expedite weaning
as respiratory patterns mature [43].
Polysomnography (PSG) is the gold standard tool for diagnosing
sleep disorders [57,58] and may be more sensitive in assessing pulmonary reserve than oximetry [59]. The role of PSG in weaning
oxygen from infants with BPD is however less clear [9]. Pre discharge PSG may identify infants with immature cardiorespiratory
centres and thus those at high risk of hypoxic events in the community [60] and may also be used to exclude nocturnal hypoxaemia prior to oxygen weaning [56,61]. However, PSG is
expensive, not readily available in many centres and thus poses a
challenge for flexible, reactive weaning. Oximetry may be argued
a feasible and inexpensive alternative tool [57].
Overnight oxygen saturation studies are a common method for
weaning. Home oximetry data may enable clinicians to identify
infants suitable for weaning. Oximetry does not however accurately predict periods of wakefulness and sleep. It is therefore paramount that parents and carers observe and document this
information during the study to enable correct interpretation.
Studies should use saturation monitors with data storage facilities
to record the oxygen saturation levels and heart rate overnight. A
reduction in the duration of HOT was observed with frequent
recorded home oximetry data and monthly clinic visits in comparison to standard monthly clinic visits alone, alongside monthly
polysomnography [43].
Determining the need for supplemental oxygen pre-discharge is
important in order to avoid the potential adverse consequences
associated with HOT. We propose that an oximetry study be performed in the week immediately prior to discharge to provide an
up to date assessment and ensure the correct amount of oxygen
flow will be delivered in the home setting. Ongoing titration studies should be undertaken. Weaning can be achieved on an approximately monthly basis [42,45] and ideally more frequently [43]. A
previous, similar structured programme has demonstrated that
infants can be weaned more rapidly from oxygen without adverse
outcomes [62] (Fig. 2). Target oxygen saturations are age dependent and infants should be weaned according to age specific reference ranges [47,63] for the oxygen saturation monitor that is being
used. The suggested percentage time spent with saturations <90%
is less than BTS guidance of 5% [50], and considers oxygen saturation profiles of preterm infants recently reported by Wellington
et al (percentage time <90% 1.3%) [47]. Suggested target saturations and ODI limits based on the current evidence [64] and using
modern generation oximeters able to exclude motion artefact and
with averaging times set at 2 seconds are outlined in Table 3.
ct
394
re
393
or
390
Further research to identify and define optimal oxygen saturation indices for infants discharged from the neonatal unit.
Develop a greater understanding of the impact of differing target oxygen saturations on long term growth, neurodevelopmental and respiratory outcomes.
Better establish the optimal mode and rates of oxygen weaning
in infants with bronchopulmonary dysplasia requiring home
oxygen on discharge from the neonatal unit.
Table 3
Saturation targets for weaning oxygen using motion resistant oximeters with short
averaging times.
Corrected age post term
Minimum mean
saturations
% of time
below 90%
3% ODI
37–40 weeks
40–44 weeks
44–56 weeks (1–4 months)
Over 56 weeks (Over 4 months)
>93%
>93%
>93%
>93%
<3%
<3%
<3%
<3%
35
30
15
7
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
481
482
483
484
485
486
487
488
489
490
491
492
494
495
496
497
498
499
500
501
502
503
6
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
Paediatric Respiratory Reviews xxx (xxxx) xxx
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
510
Lucy H. Everitt: Conceptualization, Writing - original draft,
Visualization. Adejumoke Awoseyila: Writing - original draft.
Jayesh M. Bhatt: Conceptualization, Writing - review & editing.
Mark J. Johnson: Writing - review & editing. Brigitte Vollmer:
Writing - review & editing. Hazel J. Evans: Conceptualization,
Writing - review & editing, Supervision.
511
ACKNOWLEDGEMENTS
512
516
The authors would like to thank Dr Phillip Terrill for providing raw
data from his previously published work.
This research did not receive any specific grant from funding
agencies in the public, commercial, or not-for-profit sectors.
The authors declare that there is no conflict of interest.
517
References
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
[1] Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term
outcomes after extreme preterm birth in England: comparison of two birth
cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012;345:e7976.
[2] Hanna Y, Laliberté C, Ben Fadel N, Lemyre B, Thébaud B, Barrowman N, et al.
Effect of oxygen saturation targets on the incidence of bronchopulmonary
dysplasia and duration of respiratory supports in extremely preterm infants.
Paediatr Child Health 2020;25(3):173–9.
[3] National Neonatal Audit Programme (NNAP) 2019 annual report on 2018 data.
RCPCH: London, 2019.; 2019.
[4] Primhak RA, Hicks B, Shaw NJ, Donaldson GC, Balfour-Lynn IM. Use of home
oxygen for children in England and Wales. Arch Dis Child 2011;96(4):389–92.
[5] Lo J, Zivanovic S, Lunt A, Alcazar-Paris M, Andradi G, Thomas M, et al.
Longitudinal assessment of lung function in extremely prematurely born
children. Pediatr Pulmonol 2018;53(3):324–31.
[6] Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM.
Bronchopulmonary dysplasia in very low birth weight subjects and lung
function in late adolescence. Pediatrics 2006;118(1):108–13.
[7] Cheong JLY, Doyle LW. An update on pulmonary and neurodevelopmental
outcomes of bronchopulmonary dysplasia. Semin Perinatol 2018;42
(7):478–84.
[8] DeMauro SB. The impact of bronchopulmonary dysplasia on childhood
outcomes. Clin Perinatol 2018;45(3):439–52.
[9] Yeh J, McGrath-Morrow SA, Collaco JM. Oxygen weaning after hospital
discharge in children with bronchopulmonary dysplasia. Pediatr Pulmonol
2016;51(11):1206–11.
[10] Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, et al.
Association between intermittent hypoxemia or bradycardia and late death or
disability in extremely preterm infants. JAMA 2015;314(6):595–603.
[11] Tarnow-Mordi W, Stenson B, Kirby A, Juszczak E, Donoghoe M, Deshpande S,
et al. Outcomes of two trials of oxygen-saturation targets in preterm infants. N
Engl J Med 2016;374(8):749–60.
[12] Di Fiore JM, Walsh M, Wrage L, Rich W, Finer N, Carlo WA, et al. Low oxygen
saturation target range is associated with increased incidence of intermittent
hypoxemia. J Pediatr 2012;161(6):1047–52.
[13] Terrill PI, Dakin C, Hughes I, Yuill M, Parsley C. Nocturnal oxygen saturation
profiles of healthy term infants. Arch Dis Child 2015;100(1):18–23.
[14] Brockmann PE, Poets A, Poets CF. Reference values for respiratory events in
overnight polygraphy from infants aged 1 and 3months. Sleep Med 2013;14
(12):1323–7.
[15] Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH. Risk factors for pulmonary
artery hypertension in preterm infants with moderate or severe
bronchopulmonary dysplasia. Neonatology. 2012;101(1):40–6.
[16] An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, et al. Pulmonary
hypertension in preterm infants with bronchopulmonary dysplasia. Korean
Circ J 2010;40(3):131–6.
[17] Wang LY, Luo HJ, Hsieh WS, Hsu CH, Hsu HC, Chen PS, et al. Severity of
bronchopulmonary dysplasia and increased risk of feeding desaturation and
growth delay in very low birth weight preterm infants. Pediatr Pulmonol
2010;45(2):165–73.
[18] Moyer-Mileur LJ, Nielson DW, Pfeffer KD, Witte MK, Chapman DL. Eliminating
sleep-associated
hypoxemia
improves
growth
in
infants
with
bronchopulmonary dysplasia. Pediatrics 1996;98(4 Pt 1):779–83.
[19] Farquhar M, Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung
disease. Paediatr Respir Rev 2010;11(3):149–53.
[20] Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of
pulmonary hypertension in extremely low birth weight infants. Pediatrics
2012;129(3):e682–9.
[21] Berger RM, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing ZC, et al. Clinical
features of paediatric pulmonary hypertension: a registry study. Lancet
2012;379(9815):537–46.
509
513
514
U
nc
515
ct
508
re
507
or
506
of
505
[22] Collaco JM, Romer LH, Stuart BD, Coulson JD, Everett AD, Lawson EE, et al.
Frontiers in pulmonary hypertension in infants and children with
bronchopulmonary dysplasia. Pediatr Pulmonol 2012;47(11):1042–53.
[23] Benatar A, Clarke J, Silverman M. Pulmonary hypertension in infants with
chronic lung disease: non-invasive evaluation and short term effect of oxygen
treatment. Arch Dis Child Fetal Neonatal Ed 1995;72(1):F14–9.
[24] Askie LM, Darlow BA, Finer N, Schmidt B, Stenson B, Tarnow-Mordi W, et al.
Association between oxygen saturation targeting and death or disability in
extremely preterm infants in the neonatal oxygenation prospective metaanalysis collaboration. JAMA 2018;319(21):2190–201.
[25] Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation
targets and outcomes in extremely preterm infants. N Engl J Med 2003;349
(10):959–67.
[26] Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of
Prematurity (STOP-ROP), a randomized, controlled trial. I: primary
outcomes. Pediatrics. 2000;105(2):295–310.
[27] DeMauro SB, Jensen EA, Bann CM, Bell EF, Hibbs AM, Hintz SR, et al. Home
oxygen and 2-year outcomes of preterm infants with bronchopulmonary
dysplasia. Pediatrics 2019;143(5).
[28] Wellington G, Elder D, Campbell A. 24-hour oxygen saturation recordings in
preterm infants: editing artefact. Acta Paediatr 2018;107(8):1362–9.
[29] Terrill PI, Dakin C, Edwards BA, Wilson SJ, MacLean JE. A graphical method for
comparing nocturnal oxygen saturation profiles in individuals and
populations: Application to healthy infants and preterm neonates. Pediatr
Pulmonol 2018;53(5):645–55.
[30] Pozo ME, Cave A, Köroğlu OA, Litvin DG, Martin RJ, Di Fiore J, et al. Effect of
postnatal intermittent hypoxia on growth and cardiovascular regulation of rat
pups. Neonatology 2012;102(2):107–13.
[31] Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in
care practices, morbidity, and mortality of extremely preterm neonates, 1993–
2012. JAMA 2015;314(10):1039–51.
[32] Horne RSC, Fung ACH, NcNeil S, Fyfe KL, Odoi A, Wong FY. The longitudinal
effects of persistent apnea on cerebral oxygenation in infants born preterm. J
Pediatr 2017;182:79–84.
[33] Trittmann JK, Nelin LD, Klebanoff MA. Bronchopulmonary dysplasia and
neurodevelopmental outcome in extremely preterm neonates. Eur J Pediatr
2013;172(9):1173–80.
[34] Greenough A, Alexander J, Burgess S, Chetcuti PA, Cox S, Lenney W, et al. High
versus restricted use of home oxygen therapy, health care utilisation and the
cost of care in chronic lung disease infants. Eur J Pediatr 2004;163(6):292–6.
[35] BPD Saturation TARgeting (BPD STAR) [Internet]. In progress. Estimated Study
Completion Date: February 1, 2022. Available from: https://clinicaltrials.gov/
ct2/show/NCT03385330.
[36] Duijts L, van Meel ER, Moschino L, Baraldi E, Barnhoorn M, Bramer WM, et al.
European Respiratory Society guideline on long-term management of children
with bronchopulmonary dysplasia. Eur Respir J 2020;55(1).
[37] Hayes D, Wilson KC, Krivchenia K, Hawkins SMM, Balfour-Lynn IM, Gozal D,
et al. Home oxygen therapy for children. An Official American Thoracic Society
Clinical Practice Guideline. Am J Respir Crit Care Med 2019;199(3):e5–e23.
[38] Peter C, Boberski B, Bohnhorst B, Pirr S. Prescription of home oxygen therapy to
very low birth weight infants in Germany: a nationwide survey. Clin Pediatr
(Phila) 2014;53(8):726–32.
[39] Ellsbury DL, Acarregui MJ, McGuinness GA, Eastman DL, Klein JM. Controversy
surrounding the use of home oxygen for premature infants with
bronchopulmonary dysplasia. J Perinatol 2004;24(1):36–40.
[40] Palm K, Simoneau T, Sawicki G, Rhein L. Assessment of current strategies for
weaning premature infants from supplemental oxygen in the outpatient
setting. Adv Neonatal Care 2011;11(5):349–56.
[41] Hill CM, Evans HJ. The investigation of sleep disordered breathing: seeing
through a glass, darkly? Arch Dis Child 2016;101(12):1082–3.
[42] Batey N, Batra D, Dorling J, Bhatt JM. Impact of a protocol-driven unified
service for neonates with bronchopulmonary dysplasia. ERJ Open Res 2019;5
(1).
[43] Rhein L, White H, Simoneau T, Traeger N, Lahiri T, Kremer T, et al. Transmitted
home oximetry and duration of home oxygen in premature infants. Pediatrics
2020.
[44] Millard K, Hurley M, Prayle A, Spencer S, Dushyant B, Bhatt J. Weight-based
oxygen flow rate is predictive of successful weaning of long-term oxygen
therapy in babies with bronchopulmonary dysplasia. Eur Respir J 2016;48.
[45] Kapur N, Nixon G, Robinson P, Massie J, Prentice B, Wilson A, et al. Respiratory
management of infants with chronic neonatal lung disease beyond the NICU: A
position statement from the Thoracic Society of Australia and New Zealand.
Respirology 2020.
[46] Williams LZJ, McNamara D, Alsweiler JM. Intermittent hypoxemia in infants
born late preterm: a prospective cohort observational study. J Pediatr
2019;204. 89-95.e1.
[47] Wellington G, Campbell A, Elder D. Intermittent hypoxia in preterm infants:
measurement using the desaturation index. Pediatr Pulmonol 2019;54
(6):865–72.
[48] Evans HJ, Karunatilleke AS, Grantham-Hill S, Gavlak JC. A cohort study
reporting normal oximetry values in healthy infants under 4 months of age
using Masimo technology. Arch Dis Child 2018;103(9):868–72.
[49] Garde ART, Evans HJ. Home oxygen in neonatal chronic lung disease. Reference
submitted to Personal. Communications 2020.
[50] Balfour-Lynn IM, Field DJ, Gringras P, Hicks B, Jardine E, Jones RC, et al. BTS
guidelines for home oxygen in children. Thorax 2009;64(Suppl 2). ii1-26.
Pr
o
CREDIT AUTHORSHIP CONTRIBUTION STATEMENT
ed
504
7
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
YPRRV 1438
No. of Pages 9, Model 5G
12 November 2020
L.H. Everitt, A. Awoseyila, J.M. Bhatt et al.
[51] Ahmed SJ, Rich W, Finer NN. The effect of averaging time on oximetry values in
the premature infant. Pediatrics 2010;125(1):e115–21.
[52] Vagedes J, Bialkowski A, Wiechers C, Poets CF, Dietz K. A conversion formula
for comparing pulse oximeter desaturation rates obtained with different
averaging times. PLoS ONE 2014;9(1):e87280.
[53] McClure C, Jang SY, Fairchild K. Alarms, oxygen saturations, and SpO2
averaging time in the NICU. J Neonatal Perinatal Med 2016;9(4):357–62.
[54] Finer NN, Bates R, Tomat P. Low flow oxygen delivery via nasal cannula to
neonates. Pediatr Pulmonol 1996;21(1):48–51.
[55] Bancalari E, Wilson-Costello D, Iben SC. Management of infants with
bronchopulmonary dysplasia in North America. Early Hum Dev 2005;81
(2):171–9.
[56] Saletti A, Stick S, Doherty D, Simmer K. Home oxygen therapy after preterm
birth in Western Australia. J Paediatr Child Health 2004;40(9–10):519–23.
[57] Kaditis AG, Alonso Alvarez ML, Boudewyns A, Alexopoulos EI, Ersu R, Joosten K,
et al. Obstructive sleep disordered breathing in 2- to 18-year-old children:
diagnosis and management. Eur Respir J 2016;47(1):69–94.
[58] Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, et al. Diagnosis
and management of childhood obstructive sleep apnea syndrome. Pediatrics
2012;130(3):e714–55.
of
[59] McGrath-Morrow SA, Ryan T, McGinley BM, Okelo SO, Sterni LM, Collaco JM.
Polysomnography in preterm infants and children with chronic lung disease.
Pediatr Pulmonol 2012;47(2):172–9.
[60] Joosten K, de Goederen R, Pijpers A, Allegaert K. Sleep related breathing
disorders and indications for polysomnography in preterm infants. Early Hum
Dev 2017;113:114–9.
[61] Khetan R, Hurley M, Spencer S, Bhatt JM. Bronchopulmonary dysplasia within
and beyond the neonatal unit. Adv Neonatal Care 2016;16(1):17–25. quiz E12.
[62] Batey N, Dorling J, Bhatt J. PC.87 Initiating a specialist respiratory service for
neonates with chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2014;99
(Suppl 1):A66.
[63] Wong MD, Chung H, Chawla J. Using continuous overnight pulse oximetry to
guide home oxygen therapy in chronic neonatal lung disease. J Paediatr Child
Health 2020;56(2):309–16.
[64] Ong J, Williams D, Galvak J, Liddle N, Lowe P, Evans H. An observational study
to define reference ranges for the 3% desaturation index in healthy children
under 12 years using Masimo technology. 2020. Accepted for publication
Archives of Disease in Childhood.
U
nc
or
re
ct
ed
Pr
o
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
Paediatric Respiratory Reviews xxx (xxxx) xxx
8
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703